US FDA panels to discuss acetaminophen liver toxicity
This article was originally published in Scrip
Executive Summary
The US FDA's outside experts will meet in June to discuss measures to reduce the risk of liver injury from prescription and over-the-counter acetaminophen (paracetamol) products.